Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 161,019 | 85,610 | 43,425 | 288,586 | 88,035 |
| Depreciation Amortization | 60,583 | 40,124 | 20,130 | 74,229 | 51,803 |
| Income taxes - deferred | -17,962 | -9,064 | -3,874 | -113,862 | -8,768 |
| Accounts receivable | -37,649 | -39,015 | -18,911 | -4,724 | -17,773 |
| Accounts payable and accrued liabilities | 6,670 | 4,707 | 16,158 | -7,286 | -2,543 |
| Other Working Capital | -57,320 | -81,131 | -9,861 | -5,157 | -20,083 |
| Other Operating Activity | 94,056 | 77,378 | 22,823 | 17,966 | 54,736 |
| Operating Cash Flow | $209,397 | $78,609 | $69,890 | $249,752 | $145,407 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 75,791 | 75,791 |
| PPE Investments | -6,874 | -4,710 | -1,143 | -5,976 | -4,993 |
| Net Acquisitions | N/A | N/A | N/A | -448,609 | -542,531 |
| Purchase Sale Intangibles | -6,288 | -5,300 | -5,300 | -16,500 | -10,750 |
| Other Investing Activity | -6,288 | -5,300 | -5,300 | -16,500 | -10,750 |
| Investing Cash Flow | $-13,162 | $-10,010 | $-6,443 | $-395,294 | $-482,483 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 553,425 | 553,425 | 0 | 450,916 | 450,916 |
| Debt Repayment | -464,517 | -463,124 | -5,938 | -11,875 | -5,938 |
| Common Stock Issued | 23,577 | 15,463 | 9,609 | 25,003 | 20,995 |
| Common Stock Repurchased | -102,397 | -53,578 | N/A | N/A | 0 |
| Other Financing Activity | -5,221 | -1,597 | -538 | -15,514 | -21,033 |
| Financing Cash Flow | $4,867 | $50,589 | $3,133 | $448,530 | $444,940 |
| Exchange Rate Effect | 164 | -2,077 | -3,265 | 2,132 | -147 |
| Beginning Cash Position | 387,196 | 387,196 | 387,196 | 82,076 | 82,076 |
| End Cash Position | 588,462 | 504,307 | 450,511 | 387,196 | 189,793 |
| Net Cash Flow | $201,266 | $117,111 | $63,315 | $305,120 | $107,717 |
| Free Cash Flow | |||||
| Operating Cash Flow | 209,397 | 78,609 | 69,890 | 249,752 | 145,407 |
| Capital Expenditure | -6,874 | -4,710 | -1,143 | -5,976 | -4,993 |
| Free Cash Flow | 202,523 | 73,899 | 68,747 | 243,776 | 140,414 |